<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34654821</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation.</ArticleTitle><Pagination><StartPage>6025</StartPage><MedlinePgn>6025</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6025</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-021-26303-x</ELocationID><Abstract><AbstractText>A hexanucleotide repeat expansion GGGGCC in the non-coding region of C9orf72 is the most common cause of inherited amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Toxic dipeptide repeats (DPRs) are synthesized from GGGGCC via repeat-associated non-AUG (RAN) translation. Here, we develop C. elegans models that express, either ubiquitously or exclusively in neurons, 75 GGGGCC repeats flanked by intronic C9orf72 sequence. The worms generate DPRs (poly-glycine-alanine [poly-GA], poly-glycine-proline [poly-GP]) and poly-glycine-arginine [poly-GR]), display neurodegeneration, and exhibit locomotor and lifespan defects. Mutation of a non-canonical translation-initiating codon (CUG) upstream of the repeats selectively reduces poly-GA steady-state levels and ameliorates disease, suggesting poly-GA is pathogenic. Importantly, loss-of-function mutations in the eukaryotic translation initiation factor 2D (eif-2D/eIF2D) reduce poly-GA and poly-GP levels, and increase lifespan in both C. elegans models. Our in vitro studies in mammalian cells yield similar results. Here, we show a conserved role for eif-2D/eIF2D in DPR expression.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sonobe</LastName><ForeName>Yoshifumi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-7738-8902</Identifier><AffiliationInfo><Affiliation>University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aburas</LastName><ForeName>Jihad</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6608-3513</Identifier><AffiliationInfo><Affiliation>University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Gopinath</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleming</LastName><ForeName>Andrew C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-5889-871X</Identifier><AffiliationInfo><Affiliation>The Ken &amp; Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghadge</LastName><ForeName>Ghanashyam</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Priota</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC London Institute of Medical Sciences, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Sciences, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warren</LastName><ForeName>Eleanor C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>MRC London Institute of Medical Sciences, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Sciences, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Yuanzheng</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-1493-1167</Identifier><AffiliationInfo><Affiliation>Neuromuscular &amp; Movement Disorders, Biogen, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kankel</LastName><ForeName>Mark W</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0001-7837-8044</Identifier><AffiliationInfo><Affiliation>Neuromuscular &amp; Movement Disorders, Biogen, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Andr&#xe9; E X</ForeName><Initials>AEX</Initials><AffiliationInfo><Affiliation>MRC London Institute of Medical Sciences, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Sciences, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiskinis</LastName><ForeName>Evangelos</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Ken &amp; Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gendron</LastName><ForeName>Tania F</ForeName><Initials>TF</Initials><Identifier Source="ORCID">0000-0002-7335-2627</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Fen-Biao</ForeName><Initials>FB</Initials><Identifier Source="ORCID">0000-0001-8873-5404</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Roos</LastName><ForeName>Raymond P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0002-0613-4048</Identifier><AffiliationInfo><Affiliation>University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA. rroos@neurology.bsd.uchicago.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA. rroos@neurology.bsd.uchicago.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior, University of Chicago, Chicago, IL, USA. rroos@neurology.bsd.uchicago.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kratsios</LastName><ForeName>Paschalis</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1363-9271</Identifier><AffiliationInfo><Affiliation>University of Chicago Medical Center, 5841S. Maryland Avenue, Chicago, IL, 60637, USA. pkratsios@uchicago.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior, University of Chicago, Chicago, IL, USA. pkratsios@uchicago.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, University of Chicago, Chicago, IL, USA. pkratsios@uchicago.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P40 OD010440</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MC_UP_1102/6</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS101986</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS104219</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 NS057553</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS057553</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9DLQ4CIU6V</RegistryNumber><NameOfSubstance UI="D011392">Proline</NameOfSubstance></Chemical><Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber><NameOfSubstance UI="D000409">Alanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>TE7660XO1C</RegistryNumber><NameOfSubstance UI="D005998">Glycine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lab Anim (NY). 2022 Jan;51(1):8</RefSource><PMID Version="1">34949851</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005998" MajorTopicYN="N">Glycine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011392" MajorTopicYN="N">Proline</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>16</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34654821</ArticleId><ArticleId IdType="pmc">PMC8519953</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-26303-x</ArticleId><ArticleId IdType="pii">10.1038/s41467-021-26303-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, Cleary JD, Ranum LPW. Repeat-associated non-ATG translation: molecular mechanisms and contribution to neurological disease. Annu. Rev. Neurosci. 2019;42:227&#x2013;247. doi: 10.1146/annurev-neuro-070918-050405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-070918-050405</ArticleId><ArticleId IdType="pmc">PMC6687071</ArticleId><ArticleId IdType="pubmed">30909783</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Taylor JP. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol. Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl Acad. Sci. USA. 2013;110:E4968&#x2013;4977. doi: 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann DM, et al. Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol. Commun. 2013;1:68. doi: 10.1186/2051-5960-1-68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-68</ArticleId><ArticleId IdType="pmc">PMC3893586</ArticleId><ArticleId IdType="pubmed">24252525</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, et al. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 2015;130:845&#x2013;861. doi: 10.1007/s00401-015-1476-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1476-2</ArticleId><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs G, et al. Kinetic pathway of 40S ribosomal subunit recruitment to hepatitis C virus internal ribosome entry site. Proc. Natl Acad. Sci. USA. 2015;112:319&#x2013;325. doi: 10.1073/pnas.1421328111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1421328111</ArticleId><ArticleId IdType="pmc">PMC4299178</ArticleId><ArticleId IdType="pubmed">25516984</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivares E, et al. The 5&#x2019; untranslated region of the human T-cell lymphotropic virus type 1 mRNA enables cap-independent translation initiation. J. Virol. 2014;88:5936&#x2013;5955. doi: 10.1128/JVI.00279-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00279-14</ArticleId><ArticleId IdType="pmc">PMC4093887</ArticleId><ArticleId IdType="pubmed">24623421</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada SB, et al. RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats. Nat. Neurosci. 2019;22:1383&#x2013;1388. doi: 10.1038/s41593-019-0455-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0455-7</ArticleId><ArticleId IdType="pmc">PMC6713615</ArticleId><ArticleId IdType="pubmed">31358992</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, et al. Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc. Natl Acad. Sci. USA. 2008;105:18139&#x2013;18144. doi: 10.1073/pnas.0801313105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0801313105</ArticleId><ArticleId IdType="pmc">PMC2587604</ArticleId><ArticleId IdType="pubmed">18599441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayhan F, et al. SCA8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF3F. EMBO J. 2018;37:e99023. doi: 10.15252/embj.201899023.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201899023</ArticleId><ArticleId IdType="pmc">PMC6166133</ArticleId><ArticleId IdType="pubmed">30206144</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LD, et al. eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS. Acta Neuropathol. Commun. 2019;7:62. doi: 10.1186/s40478-019-0711-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0711-9</ArticleId><ArticleId IdType="pmc">PMC6485101</ArticleId><ArticleId IdType="pubmed">31023341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Park SM, Park JH, Keum SJ, Jang SK. eIF2A mediates translation of hepatitis C viral mRNA under stress conditions. EMBO J. 2011;30:2454&#x2013;2464. doi: 10.1038/emboj.2011.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.146</ArticleId><ArticleId IdType="pmc">PMC3116280</ArticleId><ArticleId IdType="pubmed">21556050</ArticleId></ArticleIdList></Reference><Reference><Citation>Starck SR, et al. Translation from the 5&#x2019; untranslated region shapes the integrated stress response. Science. 2016;351:aad3867. doi: 10.1126/science.aad3867.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad3867</ArticleId><ArticleId IdType="pmc">PMC4882168</ArticleId><ArticleId IdType="pubmed">26823435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendoel A, et al. Translation from unconventional 5&#x2019; start sites drives tumour initiation. Nature. 2017;541:494&#x2013;499. doi: 10.1038/nature21036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21036</ArticleId><ArticleId IdType="pmc">PMC5287289</ArticleId><ArticleId IdType="pubmed">28077873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y, et al. Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiol. Dis. 2018;116:155&#x2013;165. doi: 10.1016/j.nbd.2018.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.05.009</ArticleId><ArticleId IdType="pmc">PMC6331062</ArticleId><ArticleId IdType="pubmed">29792928</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, et al. CRISPR-Cas9 screens identify the RNA helicase DDX3X as a repressor of C9ORF72 (GGGGCC)n repeat-associated non-AUG translation. Neuron. 2019;104:885&#x2013;898. doi: 10.1016/j.neuron.2019.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.09.003</ArticleId><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, et al. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science. 2016;353:708&#x2013;712. doi: 10.1126/science.aaf7791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf7791</ArticleId><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M, Rouleau GA, Dion PA, Parker JA. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS ONE. 2013;8:e83450. doi: 10.1371/journal.pone.0083450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083450</ArticleId><ArticleId IdType="pmc">PMC3861484</ArticleId><ArticleId IdType="pubmed">24349511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji YJ, et al. C9orf72/ALFA-1 controls TFEB/HLH-30-dependent metabolism through dynamic regulation of Rag GTPases. PLoS Genet. 2020;16:e1008738. doi: 10.1371/journal.pgen.1008738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1008738</ArticleId><ArticleId IdType="pmc">PMC7188304</ArticleId><ArticleId IdType="pubmed">32282804</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrionero A, Horvitz HR. A C9orf72 ALS/FTD ortholog acts in endolysosomal degradation and lysosomal homeostasis. Curr. Biol. 2018;28:1522&#x2013;1535.e1525. doi: 10.1016/j.cub.2018.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.03.063</ArticleId><ArticleId IdType="pubmed">29731301</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanakis N, Carrera I, Hobert O. Regulatory logic of pan-neuronal gene expression in C. elegans. Neuron. 2015;87:733&#x2013;750. doi: 10.1016/j.neuron.2015.07.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.07.031</ArticleId><ArticleId IdType="pmc">PMC4545498</ArticleId><ArticleId IdType="pubmed">26291158</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, et al. In situ structure of neuronal C9orf72 poly-GA aggregates reveals proteasome recruitment. Cell. 2018;172:696&#x2013;705. doi: 10.1016/j.cell.2017.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.030</ArticleId><ArticleId IdType="pmc">PMC6035389</ArticleId><ArticleId IdType="pubmed">29398115</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YJ, Jeng US, Chiang YL, Hwang IS, Chen YR. The glycine-alanine dipeptide repeat from C9orf72 hexanucleotide expansions forms toxic amyloids possessing cell-to-cell transmission properties. J. Biol. Chem. 2016;291:4903&#x2013;4911. doi: 10.1074/jbc.M115.694273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.694273</ArticleId><ArticleId IdType="pmc">PMC4777828</ArticleId><ArticleId IdType="pubmed">26769963</ArticleId></ArticleIdList></Reference><Reference><Citation>Green KM, et al. RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat. Commun. 2017;8:2005. doi: 10.1038/s41467-017-02200-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02200-0</ArticleId><ArticleId IdType="pmc">PMC5722904</ArticleId><ArticleId IdType="pubmed">29222490</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabet R, et al. CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts. Nat. Commun. 2018;9:152. doi: 10.1038/s41467-017-02643-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02643-5</ArticleId><ArticleId IdType="pmc">PMC5764992</ArticleId><ArticleId IdType="pubmed">29323119</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M, et al. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 2020;39:e100574. doi: 10.15252/embj.2018100574.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018100574</ArticleId><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, et al. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348:1151&#x2013;1154. doi: 10.1126/science.aaa9344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, et al. C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 2019;22:851&#x2013;862. doi: 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, et al. Production of poly(GA) in C9ORF72 patient motor neurons derived from induced pluripotent stem cells. Acta Neuropathol. 2019;138:1099&#x2013;1101. doi: 10.1007/s00401-019-02083-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02083-z</ArticleId><ArticleId IdType="pmc">PMC6851345</ArticleId><ArticleId IdType="pubmed">31624870</ArticleId></ArticleIdList></Reference><Reference><Citation>Javer A, Ripoll-S&#xe1;nchez L, Brown AEX. Powerful and interpretable behavioural features for quantitative phenotyping of Caenorhabditis elegans. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2018;373:20170375. doi: 10.1098/rstb.2017.0375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2017.0375</ArticleId><ArticleId IdType="pmc">PMC6158219</ArticleId><ArticleId IdType="pubmed">30201839</ArticleId></ArticleIdList></Reference><Reference><Citation>Yemini E, Jucikas T, Grundy LJ, Brown AE, Schafer WR. A database of Caenorhabditis elegans behavioral phenotypes. Nat. Methods. 2013;10:877&#x2013;879. doi: 10.1038/nmeth.2560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2560</ArticleId><ArticleId IdType="pmc">PMC3962822</ArticleId><ArticleId IdType="pubmed">23852451</ArticleId></ArticleIdList></Reference><Reference><Citation>Dmitriev SE, et al. GTP-independent tRNA delivery to the ribosomal P-site by a novel eukaryotic translation factor. J. Biol. Chem. 2010;285:26779&#x2013;26787. doi: 10.1074/jbc.M110.119693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.119693</ArticleId><ArticleId IdType="pmc">PMC2930676</ArticleId><ArticleId IdType="pubmed">20566627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearse MG, Wilusz JE. Non-AUG translation: a new start for protein synthesis in eukaryotes. Genes Dev. 2017;31:1717&#x2013;1731. doi: 10.1101/gad.305250.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.305250.117</ArticleId><ArticleId IdType="pmc">PMC5666671</ArticleId><ArticleId IdType="pubmed">28982758</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon HJ, Donahue TF. The suil suppressor locus in Saccharomyces cerevisiae encodes a translation factor that functions during tRNA(iMet) recognition of the start codon. Mol. Cell Biol. 1992;12:248&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC364089</ArticleId><ArticleId IdType="pubmed">1729602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomakin IB, Shirokikh NE, Yusupov MM, Hellen CU, Pestova TV. The fidelity of translation initiation: reciprocal activities of eIF1, IF3 and YciH. EMBO J. 2006;25:196&#x2013;210. doi: 10.1038/sj.emboj.7600904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600904</ArticleId><ArticleId IdType="pmc">PMC1356347</ArticleId><ArticleId IdType="pubmed">16362046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, et al. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2alpha phosphorylation. Nat. Commun. 2018;9:51. doi: 10.1038/s41467-017-02495-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02495-z</ArticleId><ArticleId IdType="pmc">PMC5754368</ArticleId><ArticleId IdType="pubmed">29302060</ArticleId></ArticleIdList></Reference><Reference><Citation>May S, et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 2014;128:485&#x2013;503. doi: 10.1007/s00401-014-1329-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1329-4</ArticleId><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 2014;128:505&#x2013;524. doi: 10.1007/s00401-014-1336-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1336-5</ArticleId><ArticleId IdType="pmc">PMC4159567</ArticleId><ArticleId IdType="pubmed">25173361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci. 2016;19:668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, et al. Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. 2017;134:241&#x2013;254. doi: 10.1007/s00401-017-1711-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1711-0</ArticleId><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B, et al. Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD. EMBO J. 2020;39:e102811. doi: 10.15252/embj.2019102811.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102811</ArticleId><ArticleId IdType="pmc">PMC7156967</ArticleId><ArticleId IdType="pubmed">32175624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, et al. Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron. 2020;105:645&#x2013;662. doi: 10.1016/j.neuron.2019.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.11.007</ArticleId><ArticleId IdType="pmc">PMC7391607</ArticleId><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudich P, et al. Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans. Hum. Mol. Genet. 2017;26:4916&#x2013;4928. doi: 10.1093/hmg/ddx372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx372</ArticleId><ArticleId IdType="pmc">PMC5886095</ArticleId><ArticleId IdType="pubmed">29036691</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W, Van Den Bosch L. RNA toxicity in non-coding repeat expansion disorders. EMBO J. 2020;39:e101112. doi: 10.15252/embj.2018101112.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018101112</ArticleId><ArticleId IdType="pmc">PMC6939197</ArticleId><ArticleId IdType="pubmed">31721251</ArticleId></ArticleIdList></Reference><Reference><Citation>Skabkin MA, et al. Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling. Genes Dev. 2010;24:1787&#x2013;1801. doi: 10.1101/gad.1957510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1957510</ArticleId><ArticleId IdType="pmc">PMC2922506</ArticleId><ArticleId IdType="pubmed">20713520</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain T, et al. Structural changes enable start codon recognition by the eukaryotic translation initiation complex. Cell. 2014;159:597&#x2013;607. doi: 10.1016/j.cell.2014.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.10.001</ArticleId><ArticleId IdType="pmc">PMC4217140</ArticleId><ArticleId IdType="pubmed">25417110</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur A, Hinnebusch AG. eIF1 Loop 2 interactions with Met-tRNA(i) control the accuracy of start codon selection by the scanning preinitiation complex. Proc. Natl Acad. Sci. USA. 2018;115:E4159&#x2013;E4168. doi: 10.1073/pnas.1800938115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800938115</ArticleId><ArticleId IdType="pmc">PMC5939108</ArticleId><ArticleId IdType="pubmed">29666249</ArticleId></ArticleIdList></Reference><Reference><Citation>Skabkin MA, Skabkina OV, Hellen CU, Pestova TV. Reinitiation and other unconventional posttermination events during eukaryotic translation. Mol. Cell. 2013;51:249&#x2013;264. doi: 10.1016/j.molcel.2013.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.05.026</ArticleId><ArticleId IdType="pmc">PMC4038429</ArticleId><ArticleId IdType="pubmed">23810859</ArticleId></ArticleIdList></Reference><Reference><Citation>Young DJ, et al. Tma64/eIF2D, Tma20/MCT-1, and Tma22/DENR recycle post-termination 40S subunits in vivo. Mol. Cell. 2018;71:761&#x2013;774. doi: 10.1016/j.molcel.2018.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.07.028</ArticleId><ArticleId IdType="pmc">PMC6225905</ArticleId><ArticleId IdType="pubmed">30146315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinoviev A, Hellen CUT, Pestova TV. Multiple mechanisms of reinitiation on bicistronic calicivirus mRNAs. Mol. Cell. 2015;57:1059&#x2013;1073. doi: 10.1016/j.molcel.2015.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.01.039</ArticleId><ArticleId IdType="pmc">PMC4521216</ArticleId><ArticleId IdType="pubmed">25794616</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasudevan D, et al. Translational induction of ATF4 during integrated stress response requires noncanonical initiation factors eIF2D and DENR. Nat. Commun. 2020;11:4677. doi: 10.1038/s41467-020-18453-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18453-1</ArticleId><ArticleId IdType="pmc">PMC7495428</ArticleId><ArticleId IdType="pubmed">32938929</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusi SK, et al. The alternative initiation factor eIF2A plays key role in RAN translation of myotonic dystrophy type 2 CCUG&#x2022;CAGG repeats. Hum. Mol. Genet. 2021;30:1020&#x2013;1029. doi: 10.1093/hmg/ddab098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab098</ArticleId><ArticleId IdType="pmc">PMC8170841</ArticleId><ArticleId IdType="pubmed">33856033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon OS, et al. An mRNA-specific tRNAi carrier eIF2A plays a pivotal role in cell proliferation under stress conditions: stress-resistant translation of c-Src mRNA is mediated by eIF2A. Nucleic Acids Res. 2017;45:296&#x2013;310. doi: 10.1093/nar/gkw1117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1117</ArticleId><ArticleId IdType="pmc">PMC5224483</ArticleId><ArticleId IdType="pubmed">27899592</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77:71&#x2013;94. doi: 10.1093/genetics/77.1.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/genetics/77.1.71</ArticleId><ArticleId IdType="pmc">PMC1213120</ArticleId><ArticleId IdType="pubmed">4366476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendi, A. &amp; Mizumoto, K. GFPnovo2, a brighter GFP variant for in vivo labeling in C. elegans. MicroPubl. Biol.2018, 10.17912/49YB-7K39 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282520</ArticleId><ArticleId IdType="pubmed">32550394</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671&#x2013;675. doi: 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendrel M, Rapti G, Richmond JE, Bessereau JL. A secreted complement-control-related protein ensures acetylcholine receptor clustering. Nature. 2009;461:992&#x2013;996. doi: 10.1038/nature08430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08430</ArticleId><ArticleId IdType="pubmed">19794415</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj A, van den Bogaard P, Rifkin SA, van Oudenaarden A, Tyagi S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat. Methods. 2008;5:877&#x2013;879. doi: 10.1038/nmeth.1253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1253</ArticleId><ArticleId IdType="pmc">PMC3126653</ArticleId><ArticleId IdType="pubmed">18806792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadge GD, et al. Knockdown of GADD34 in neonatal mutant SOD1 mice ameliorates ALS. Neurobiol. Dis. 2020;136:104702. doi: 10.1016/j.nbd.2019.104702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104702</ArticleId><ArticleId IdType="pubmed">31837419</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman NR, et al. Neuroblastoma &#xd7; spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega JA, et al. Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS/FTD C9orf72 toxicity. Neuron. 2020;106:90&#x2013;107. doi: 10.1016/j.neuron.2020.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.01.020</ArticleId><ArticleId IdType="pmc">PMC7272217</ArticleId><ArticleId IdType="pubmed">32059759</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulting GL, et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 2011;29:279&#x2013;286. doi: 10.1038/nbt.1783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1783</ArticleId><ArticleId IdType="pmc">PMC3229307</ArticleId><ArticleId IdType="pubmed">21293464</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade NS, et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol. Neurodegener. 2020;15:13. doi: 10.1186/s13024-020-00365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00365-9</ArticleId><ArticleId IdType="pmc">PMC7041170</ArticleId><ArticleId IdType="pubmed">32093728</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan G, et al. CRISPR deletion of the C9ORF72 promoter in ALS/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration. Acta Neuropathol. 2020;140:81&#x2013;84. doi: 10.1007/s00401-020-02154-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02154-6</ArticleId><ArticleId IdType="pmc">PMC7300081</ArticleId><ArticleId IdType="pubmed">32266467</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>